MTIC
OM icon

Missouri Trust & Investment Company’s Outset Medical OM Stock Holding History

Missouri Trust & Investment Company’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1
Closed -$14 – 414
2025
Q3 		$14 Hold
1
– – ﹤0.01% 412
2025
Q2 		$19 Buy
+1
New +$16 ﹤0.01% 425
2025
Q1 		– Sell
-2
Closed -$26 – 441
2024
Q4 		$26 Hold
2
– – ﹤0.01% 435
2024
Q3 		$16 Hold
2
– – ﹤0.01% 396
2024
Q2 		$89 Hold
2
– – ﹤0.01% 400
2024
Q1 		$51 Hold
2
– – ﹤0.01% 410
2023
Q4 		$124 Hold
2
– – ﹤0.01% 424
2023
Q3 		$250 Hold
2
– – ﹤0.01% 415
2023
Q2 		$503 Hold
2
– – ﹤0.01% 453
2023
Q1 		$423 Hold
2
– – ﹤0.01% 348
2022
Q4 		$1K Hold
2
– – ﹤0.01% 327
2022
Q3 		$1K Hold
2
– – ﹤0.01% 337
2022
Q2 		$1K Hold
2
– – ﹤0.01% 350
2022
Q1 		$1K Hold
2
– – ﹤0.01% 344
2021
Q4 		$1K Buy
+2
New +$1.48K ﹤0.01% 386

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Missouri Trust & Investment Company's OM Position: Q4 2025 in Review

Missouri Trust & Investment Company sold out of Outset Medical (OM) in Q4 2025, closing a stake of 1 share — an estimated $14 sold.

Missouri Trust & Investment Company first reported a position in OM in Q4 2021 and held it in 15 quarters. The position peaked at $1K in Q4 2022. 100 funds tracked by Wall St. Rank hold OM as of Q4 2025.

  • Missouri Trust & Investment Company reported no remaining Outset Medical position as of Q4 2025 after selling out during the quarter.
  • Missouri Trust & Investment Company sold 1 Outset Medical share in Q4 2025, an estimated $14.
  • Missouri Trust & Investment Company first reported a position in Outset Medical in Q4 2021 and held it in 15 quarters.
  • Missouri Trust & Investment Company's Outset Medical position peaked at $1K in Q4 2022.
  • 100 funds tracked by Wall St. Rank held Outset Medical as of Q4 2025.

Based on Missouri Trust & Investment Company's 13F filing for Q4 2025, filed 13 Feb 2026.